CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 134 filers reported holding CARIBOU BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,266,040 | +12.5% | 474,067 | 0.0% | 15.18% | -3.3% |
Q2 2023 | $2,014,785 | -20.0% | 474,067 | 0.0% | 15.70% | +1216.9% |
Q1 2023 | $2,517,296 | -15.4% | 474,067 | 0.0% | 1.19% | -12.9% |
Q4 2022 | $2,977,141 | -40.5% | 474,067 | 0.0% | 1.37% | -65.4% |
Q3 2022 | $5,001,000 | +94.3% | 474,067 | 0.0% | 3.96% | -0.4% |
Q2 2022 | $2,574,000 | -40.9% | 474,067 | 0.0% | 3.98% | -16.4% |
Q1 2022 | $4,352,000 | -39.2% | 474,067 | 0.0% | 4.76% | -25.0% |
Q4 2021 | $7,154,000 | -36.8% | 474,067 | 0.0% | 6.35% | -55.1% |
Q3 2021 | $11,316,000 | – | 474,067 | – | 14.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
72 Investment Holdings, LLC | 474,067 | $2,266,040 | 15.18% |
Elmwood Wealth Management, Inc. | 2,364,415 | $11,301,904 | 5.45% |
PFM Health Sciences, LP | 6,724,715 | $32,144,138 | 1.51% |
SILVERARC CAPITAL MANAGEMENT, LLC | 892,786 | $4,267,517 | 1.29% |
Avidity Partners Management LP | 6,050,212 | $28,920,013 | 1.16% |
Paradigm Biocapital Advisors LP | 2,944,513 | $14,074,772 | 0.96% |
Kynam Capital Management, LP | 1,068,527 | $5,107,559 | 0.84% |
Green Alpha Advisors, LLC | 110,524 | $528,305 | 0.41% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,500,000 | $16,730,000 | 0.37% |
Bruce & Co., Inc. | 200,000 | $956,000 | 0.33% |